Using arrays to screen embryos during an in vitro fertilization cycle can improve pregnancy rates, according to a new study.

Pacific Reproductive Center, a Torrance, Calif.-based IVF clinic, blindly randomized 103 IVF cycles. In a treatment group of 55 cycles, the center used BlueGnome 24sure comparative genomic hybridization arrays to screen day-5 biopsies for aneuploid chromosomes prior to implantation of a single euploid embryo, while in a control group of 48 cycles, single embryos were selected using existing morphological scorecard approaches.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.